fda warning letters bpc-157 2023 BPC-157: Miracle Healing Peptide or Hidden Danger? fda warning letter bpc-157 unapproved
Description
SS-31, a mitochondria-targeting peptide, addresses the energy deficit that underlies much neurodegenerative pathology
doi: 10.1111/bph.13489
Timeline depends on the indication
Limited Mobility or Weakness To investigate bone-related causes of movement issues
1 with declared tamoxifen, tamoxifen presence was not confirmed by LC-QTOF-MS/MS or XRPD
